輸血替代療法的效益
腫瘤科
Should intravenous iron be the standard of care in oncology? （開啟新視窗）
出處: J Clin Oncol 2008;26(10):1579-81.
檢索: PubMed 18375888
DOI碼: 10.1200/JCO.2007.15.4609
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. （開啟新視窗）
出處: Acta Oncol 2008;47(6):1009-17.
檢索: PubMed 18770060
DOI碼: 10.1080/02841860701744498
Cost of outpatient blood transfusion in cancer patients. （開啟新視窗）
出處: J Clin Oncol 2000;18(14):2755-61.
檢索: PubMed 10894876
DOI碼: 10.1200/JCO.2000.18.14.2755
Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. （開啟新視窗）
出處: Transfusion 2015;55(12):2807-15.
檢索: PubMed 26264557
DOI碼: 10.1111/trf.13260